Pluristem Therapeutics receives European Patent on core 3D cell expansion technology (News-Medical-Net)
Pluristem Therapeutics Inc. today announced that it has been granted a European Patent on its core 3D cell expansion technology. The granting of the European patent follows the issuance of several corresponding US patents as well as corresponding patents in ten additional jurisdictions.
Leave a Response
You must be logged in to post a comment.
